In addition to this, the administration of subanesthetic ketamine in three patients with depression caused an abrupt decrease in the depressive symptoms which may be associated with an acute increase in the plasma mTOR, GSK-3 expression, and phosphorylation of the eEF2 [219]. The gene discussed is MTOR; the disease is depressive disorder.